戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 matory monocytes (Mo)/macrophages (MPhi) and impaired healing.
2 which suffer from neutrophil persistence and impaired healing.
3 een associated with chronic inflammation and impaired healing.
4  is associated with chronic inflammation and impaired healing.
5 f NRF2-activating compounds in patients with impaired healing.
6 agents, is giving new hope to the problem of impaired healing.
7 clinical studies and in our animal models of impaired healing.
8 ammatory monocytes (Mo)/macrophages (MO) and impaired healing.
9 , there is an increased risk of fracture and impaired healing.
10 process and deficiencies in the MMP9 lead to impaired healing.
11 iabetic complications, such as infection and impaired healing after tissue damage.
12  tailored "living bandage" for patients with impaired healing and can serve as prototype for the deve
13    Corneal injury in HO-2 null mice leads to impaired healing and chronic inflammatory complications,
14 urnal rhythm disruption immediately after MI impaired healing and exacerbated maladaptive cardiac rem
15  of numerous tissues, and they contribute to impaired healing and fibrosis.
16 ic wounds may serve as a molecular marker of impaired healing and may provide future targets for ther
17 istent gaps exist in scientific knowledge of impaired healing and the ability of clinicians to reduce
18 nds is believed to play an important role in impaired healing and the development of infection-relate
19 FAs exhibited positive correlations with OA, impaired healing, and inflammatory adipokines.
20                   Prolonged inflammation and impaired healing are hallmarks of the diabetic response
21                        Mechanisms underlying impaired healing are not defined.
22 beta-catenin/c-myc pathway(s) contributes to impaired healing by inhibiting keratinocyte migration an
23 in, thus providing a potential mechanism for impaired healing by local B2AR activation in wound-edge
24 ic foot ulcers and other chronic wounds with impaired healing can be treated with bioengineered skin
25 pted homeostasis, increased injury risk, and impaired healing capacity.
26  to the persistent inflammatory response and impaired healing characteristic of these wounds.
27             Interleukin-23p19-/- mice showed impaired healing compared with wild-type mice, as seen b
28 migration by impairing connexin 43, and that impaired healing during NEC is associated with reduced g
29        Chronic inflammation is a hallmark of impaired healing in a plethora of tissues, including ski
30 how that local injection of DHEA accelerates impaired healing in an ageing mouse colony.
31                             DHEA accelerated impaired healing in an impaired healing model (mice rend
32 actors in chronic wounds and the reversal of impaired healing in animal models, pressure ulcer trials
33 the molecular mechanisms and pathogenesis of impaired healing in chronic ulcers is a serious health i
34 may contribute to sustained inflammation and impaired healing in chronic wounds.
35        The EP4 agonist markedly improved the impaired healing in COX-2(-/-) mice, as evidenced by res
36 en, to determine the contribution of TSP2 to impaired healing in diabetes, we developed a novel diabe
37 und macrophage phenotype that contributes to impaired healing in diabetes.
38 cemia-induced TSP2 expression contributes to impaired healing in diabetes.
39 ive shift in wound microbiota coincides with impaired healing in diabetic mice (Lepr(db/db); db/db).
40 ng to persistent accumulation of Mo/MPhi and impaired healing in diabetic mice.
41 ting to persistent accumulation of Mo/MO and impaired healing in diabetic mice.
42  is a major co-morbidity that contributes to impaired healing in diabetic wounds.
43 ecifically, we show that in vivo FMT detects impaired healing in FXIII-/- mice.
44            Cited2 deficient cornea exhibited impaired healing in response to corneal epithelial debri
45 aging to compare the course of efficient and impaired healing in wild-type and FXIII-/- mice, respect
46 mice but reduced by 90% in CD73 mutants, (3) impaired healing involves M1-driven immune response with
47 issue formation in healing gingiva, and that impaired healing is associated with factors that decreas
48                                              Impaired healing is common in wounds infected with the m
49 und healing complications (wound dehiscence, impaired healing, lymphocele, and incisional hernia) wit
50                         Patients at risk for impaired healing may benefit from prophylactic measures
51      DHEA accelerated impaired healing in an impaired healing model (mice rendered hypogonadal) assoc
52 peptic ulcer or troublesome dyspepsia led to impaired healing of gastric ulcers and did not affect th
53        In addition, TNF-alpha mice displayed impaired healing of incisional and excisional skin wound
54                      We investigated whether impaired healing of injured PHT gastric mucosa is due to
55 ntium Correspondingly, AQP3(-/-) mice showed impaired healing of superficial wounds in the colon and
56  function but is insufficient to correct the impaired healing of the HO-2(-/-) cornea, suggesting tha
57 uring the past 3 decades presented issues of impaired healing or increased risk of cardiac rupture or
58 akage and reduced fibroplasia, indicating an impaired healing response consistent with angiogenesis b
59 wounds inflicted in space exhibit delayed or impaired healing responses.
60 d2(-/-) skin microbiome dominated and caused impaired healing, shown in cross-fostering experiments o
61                                              Impaired healing states are characterized by excessive p
62 ith chronic Ly-6C(hi) monocytosis results in impaired healing, underscoring the need for a balanced a
63 Local and systemic factors can contribute to impaired healing, with the potential to prolong function